Chairman Guo Guangchang personally attended the launching ceremony. The highest-level leader from Chongqing who attended this event was Tang Liangzhi, deputy secretary of the Municipal Party Committee.

　　Fosun Group's global headquarters is located in Shanghai, with a Beijing regional headquarters in China, and is planning to build a southern headquarters in Guangzhou. The establishment of the Southwest Headquarters in Chongqing is undoubtedly an important step in the development of the western region.

　　Fosun entered Chongqing around 2002. Up to now, Fosun Group and its invested companies have invested in fields such as health, finance, raw materials and real estate in Chongqing, with a total investment of more than RMB 10 billion.

　　The investment and operation results are sufficient to explain the correctness of entering the Chongqing market.

　　1. Around 2001, the company held a controlling stake in Chongqing Pharmaceutical Industry Research Institute. The research institute was established in 1950. In 2001, as a unit of the first batch of scientific research institutes in Chongqing, Fosun Pharma and Chongqing Pharmaceutical (Group) Co., Ltd. jointly established Chongqing Pharmaceutical Industry Research Institute Co., Ltd. (hereinafter referred to as " Chongqing Medical Engineering Institute"). It is now one of the well-known drug research and development bases in China.

　　2. In June 2002, Fosun Industrial invested 69 million yuan and became the largest shareholder of Chongqing Yaoyou with 51% of the shares.

　　Investment shareholders include Fosun Pharma, Jiangsu Wanbang Biochemical and Pharmaceutical Co., Ltd., Chongqing Pharmaceutical Industry Research Institute, etc. The company is headquartered in Chongqing, China, and has two wholly-owned subsidiaries (research laboratories) in Shanghai, China and San Francisco, USA, thus forming a unique international layout of "two countries and three places", and implementing 24-hour continuous scientific research .

　　5. In 2016, participated in the major asset restructuring of Jianfeng Chemical. As an existing shareholder of Chongqing Medical Stocks, Fosun Pharma and its controlling subsidiary Guilin Pharmaceutical Co., Ltd. intend to participate in the major asset restructuring of Jianfeng Chemical with a total of 13.717 million Chongqing Medical Stocks. Jianfeng Chemical plans to issue shares in a non-public manner. As consideration for the transfer of the underlying assets. This reorganization is currently underway

　　In 2013, it spent 700 million to acquire about 14 acres of golden land next to Luohan Temple in Yuzhong District, and will build a new commercial project forte and financial center. The project is still under construction.

　　In the field of science, technology and education, Fosun Group relies on innovative scientific research and international education resources to help Chongqing build a western innovation center and enhance the internationalization of Chongqing's education;

　　In the field of cultural, sports and tourism industry, Fosun Group will rely on Chongqing's existing tourism resources to introduce world-class tourism products suitable for the reality of Chongqing.

　　Hainajun noticed that in October 2016, senior executives of Starview Capital, a professional PPP project fund management company under Fosun Group, visited the Municipal Development and Reform Commission, the Bureau of Finance, the Urban and Rural Construction Commission, Yufu Group, and the Urban Investment Group in two days. , Jiaotong Development Investment Group and other Chongqing PPP project authorities and main implementing agencies, and conducted in-depth discussions and exchanges on some of the projects and implementing agencies in the fields of infrastructure construction, urban construction, environmental protection, energy, etc. that they are interested in.